MYCN and neuroblastoma: In particular, we dynamically monitored postoperative plasma MYCN copy number in NB patients to further evaluate the feasibility of plasma circulating cell‐free MYCN as a noninvasive indicator of NB recurrence using the developed single‐tube multiplex RT‐PCR approach.